| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Obesity is Fatal |
|
E-Articles - Obesity is Fatal
Every additional study that is done on obese people is bringing new links to light and so obesity is now being viewed as a more dangerous condition t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product han before. The reports that are publicised often never reach their tasks, or if they do then they’re ignored or dismissed by the people they are try ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ing to reach. To make an impact on the people who need to know this information, steps should be taken to force the acknowledgement of problems by th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. se people. Their backward attitude to nutritional problems needs to be revised through strong action. There are a range of different illnesses that here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe can be attributed to the fact that someone is obese. Obesity may be the cause, either directly or indirectly, of many potentially fatal conditions. T d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ere are certain illnesses, like heart disease that are well known to be exacerbated or caused by obesity, but more and more illnesses are being shown ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc to be linked to obesity. The latest scientific studies have now easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi l">linked cancer to obesity, particularly kidney cancer. The results of different studies are published repeatedly in different newspapers and ma nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically azine in the hope that they will persuade people to change their lifestyles. This has been ineffective since one of the most difficult things is tryi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ng to persuade obese people that they are the ones who need to enact the changes in their lives. The idea that they will be one of the people who is ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi naffected by the health problems is very prevalent in obese people. Even those people who realise that they can be affected are likely to be unwillin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a g to do anything to change their lifestyle. They ask why the conditions were not a problem before, which is a major misconception. A rise in the numb dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod er of obese people has lead to more studies of obesity which has brought the links between obesity and other conditions to light. One method is to we cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin gh obese people and force them to take steps to amend for each pound above an acceptable weight. This can take the form of a variety of different act tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ions including community service. Spending time attending to obese people who are suffering from diseases related to obesity could force them to face t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the harsh reality of the situation they have put themselves in. The acknowledgement of the link between those problems and their lifestyle might prov ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ide motivation to change their lifestyle. Another method would be to create an additional tax which could either be levied on their weight by pound. y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Alternatively the tax can be on different types of food depending on what their nutritional value is. The tax they pay can go towards the health car . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de that they will need for problems related to their excessive weight. This will help to potentially relieve taxes for those people who have healthy li elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ves who currently are forced to pay for those services. The more they weigh the more they must contribute to the health services they use as a result tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|